Cargando…
True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
Autores principales: | Khatri, Akshay, Raja, Mohammed, Guerra, Giselle, Natori, Yoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849506/ https://www.ncbi.nlm.nih.gov/pubmed/34897967 http://dx.doi.org/10.1111/ajt.16922 |
Ejemplares similares
-
Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
por: Mendoza, Maria A., et al.
Publicado: (2021) -
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022) -
262. COVID-19 associated fungal co-infections in Solid Organ Transplant Recipients: A single center case series
por: Khatri, Akshay M, et al.
Publicado: (2022) -
1336. Outcomes of COVID-19 in Recent Kidney Transplants Recipients at a Large Transplant Center in Miami
por: Mendoza, Maria A, et al.
Publicado: (2021) -
Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)